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bstract
Different presynaptic neuromodulation systems have been explored as possible targets to manage neurodegenerative diseases. However,
ost studies used young adult animals whereas neurodegenerative diseases are prevalent in the elderly. Thus, we now explored by Western blot
nalysis how the density of different presynaptic markers and receptors changes with aging in rat hippocampal synaptosomes (purified nerve
erminals). Compared to synaptosomal membranes from 2-month-old rats, the density of presynaptic proteins (synaptophysin or SNAP-25)
ecreased at 18–24 months. In parallel, markers of glutamatergic terminals (vGluT1 or vGluT2) and cholinergic terminal markers (vAChT)
onstantly decreased with aging from 12 to 18 months onwards, whereas the densities of GABAergic (vGAT) only decreased after 24 months.
nhibitory A1 and CB1 receptor density tended to decrease with aging, whereas facilitatory mGluR5 and P2Y1 receptor density was roughly
onstant and facilitatory A2A receptor density increased at 18–24 months. Thus aging causes an imbalance of excitatory versus inhibitory
erve terminal markers and causes a predominant decrease of inhibitory rather than facilitatory presynaptic modulation systems.
2008 Elsevier Inc. All rights reserved.
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. Introduction
There is increasing evidence indicating that dysfunction
nd loss of nerve terminals might represent one of the earli-
st modifications in the course of neurodegenerative diseases
Wishart et al., 2006). For instance, in Alzheimer’s disease,
he loss of synaptic markers, in contrast to neuronal loss,
s the parameter that correlates better with memory dys-
unction (Selkoe, 2002). Likewise, in Parkinson’s disease,
odification of firing patterns of cortico-striatal pathwaysPlease cite this article in press as: Canas, P.M., et al., Modification upo
hippocampus, Neurobiol Aging (2008), doi:10.1016/j.neurobiolaging.20
Be´zard et al., 2003) and loss of dopaminergic terminals
Herkenham et al., 1991) occur early in the asymptomatic
∗ Corresponding author. Tel.: +351 239820190; fax: +351 239822776.
E-mail address: racunha@ci.uc.pt (R.A. Cunha).
RL: http://www/cnc.cj.uc.pt/lab lef/ (R.A. Cunha).
1 These authors contributed experimentally for the present work. The
uthors are grateful to Dr. Ken Mackie for generously supply of the CB1
eceptor antibody.
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hase of the disease. In fact, this synaptic dysfunction
nd damage has been recognised as an early event in the
ourse of different other neurodegenerative diseases such
s Huntington’s (Li et al., 2001), prion’s diseases (Ferrer,
002), HIV infection (Garden et al., 2002), schizophre-
ia (Glantz et al., 2006), temporal lobe epilepsy (Ratte´
nd Lacaille, 2006) or motor neuropathies (Raff et al.,
002).
This central and initial role of synaptic dysfunction in neu-
odegenerative diseases has been the main driving force to
onceive presynaptic neuromodulation systems as candidate
argets to restraint the early modifications in these diseases.
hus, drugs activating presynaptic modulators such as adeno-
ine A1 receptors (Fredholm et al., 2005) or cannabinoid CB1
eceptors (van der Stelt and Di Marzo, 2005) might affordn aging of the density of presynaptic modulation systems in the
08.01.003
rotection against different neurodegenerative diseases.
lso, antagonists of adenosine A2A receptors (Fredholm et
l., 2005), metabotropic group 5 receptors (Flor et al., 2002)
r ATP P2Y1 receptors (Franke et al., 2006) also confer neu-
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oprotection in different animal models of brain degenerative
iseases. However, the study of novel neuroprotective strate-
ies has mostly been carried out using young adult animals,
hereas most neurodegenerative diseases are prevalent in
he elderly. The extrapolation of the conclusions reached in
oung adult animals to the context of disease progression in
he elderly can only be tentatively suggested provided that
here is no significant aging-related modification of the tar-
eted presynaptic modulation systems. As a first step to tackle
his question, we now explored by Western blot analysis how
he density of different presynaptic markers and of receptors
riggering different presynaptic modulation systems changed
ith aging in rat hippocampal nerve terminals.
. Methods
Male Wistar rats, young adults (2 months), adults (6 and
2 months) and aged (18 and 24 months), were obtained from
harles River (Barcelona, Spain). They were handled accord-
ng with the EU guidelines for use of experimental animals
86/609/EEC), the rats being anesthetized under halothane
tmosphere before being sacrificed by decapitation.
.1. Preparation of hippocampal nerve terminals
Nerve terminals from the rat hippocampus were purified
hrough sucrose and Percoll gradients (Rebola et al., 2005;
odrigues et al., 2005a). We have already validated the use of
hese hippocampal synaptosomes to study age-related mod-
fications of biochemical and functional properties of nerve
erminals (Cunha et al., 2001; Lopes et al., 1999; Rebola
t al., 2003a; Rodrigues et al., in press). Briefly, hippocam-
al tissue was homogenized in a medium containing 0.32 M
ucrose, 1 mM EDTA, 0.1% BSA and 10 mM HEPES (pH
.4). The homogenate was spun for 10 min 3000 × g at 4 ◦C
nd the supernatant spun again at 14,000 × g for 12 min. The
ellet (P2 fraction) was resuspended in 1 ml of Percoll 45%
v/v) in Krebs-HEPES-Ringer (KHR) medium (in mM: NaCl
40, EDTA 1, KCl 5, glucose 5 and HEPES 10, pH 7.4)
nd spun again at 14,000 × g for 2 min. Synaptosomes were
hen removed from the top layer, washed once with KHR
edium and resuspended in SDS-PAGE buffer (see below)
or Western blot analysis.
.2. Western blot analysis
The density of general cellular markers (tubulin and
ADPH), of general markers of nerve terminals (synap-
ophysin and SNAP-25), of markers of the phenotype of
ifferent nerve terminals (vGluT1 and 2, vGAT and vAChT)
nd of different neuromodulation system that have beenPlease cite this article in press as: Canas, P.M., et al., Modification upo
hippocampus, Neurobiol Aging (2008), doi:10.1016/j.neurobiolaging.20
nvolved in the control of neurodegeneration (adenosine
1 and A2A, cannabinoid CB1, glutamate mGluR5 and
urinergic P2Y1 receptors) was compared in hippocam-
al nerve terminals derived from rats with different ages
d
b
i
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2, 6, 12, 18 and 24 months) by Western blot analysis.
riefly, after determining the amount of protein, each sam-
le was diluted with five volumes of SDS-PAGE buffer
ontaining 30% (v/v) glycerol, 0.6 M dithiothreitol, 10%
w/v) SDS and 375 mM Tris–HCl pH 6.8, boiled at 95 ◦C
or 5 min. These diluted samples (each gel always included
amples from the different age groups for direct com-
arison) and the pre-stained molecular weight markers
Amersham Biosciences, UK) were separated by SDS-PAGE
10% with a 4% concentrating gel) under reducing con-
itions and electro-transferred to polyvinylidene difluoride
embranes (0.45m, from Amersham). After blocking for
h at room temperature with 5% milk in Tris-buffered
aline, pH 7.6 containing 0.1% Tween 20 (TBS-T), the
embranes were incubated overnight at 4 ◦C with the
ifferent antibodies, namely: widely used mouse anti--
ubulin (1:10,000 dilution, from Sigma-Portugal) and goat
nti-glyceraldeheyde-3-phosphate dehydrogenase (GAPDH,
:1000 dilution, from Santa Cruz Biotechnology, Alfagene,
ortugal); previously validated (see Pinheiro et al., 2003)
ouse anti-synaptophysin (1:1000, from Sigma) and mouse
nti-SNAP-25 (1:10,000, from Sigma); previously used
e.g. Ko¨falvi et al., 2005) guinea-pig anti-vesicular GABA
ransporter (vGAT, 1:1000, from Calbiochem, PGHitec,
ortugal), guinea-pig anti-vesicular glutamate transporters
ypes 1 and 2 (vGluT1 and vGluT2, 1:5000, from Chemi-
on) and guinea-pig anti-vesicular acetylcholine transporter
vAChT, 1:500, from Chemicon); previously validated rabbit
nti-adenosine A1 receptor (1:1000, from Affinity Biore-
gents, Golden, USA; see Rebola et al., 2003b), goat
nti-adenosine A2A receptor (1:500 dilution, from Santa Cruz
iotechnology; see Rebola et al., 2005), rabbit L-15 C-
erminus anti-CB1 receptor (1:500, generously supplied by
r. Ken Mackie, Indiana University, Bloomington, USA;
ee Ko¨falvi et al., 2005), rabbit anti-mGluR5 receptor
1:3000, from Upstate Biotechnology; see Rodrigues et al.,
005b) and goat anti-P2Y1 receptor (1:200, from Santa
ruz Biotechnology; see Rodrigues et al., 2005a). After
our washing periods for 10 min with TBS-T containing
.5% milk, the membranes were incubated with the alkaline
hosphatase-conjugated anti-goat, anti-rabbit, anti-mouse or
nti-guinea-pig secondary antibody (1:2000, from Amer-
ham) in TBS-T containing 1% milk during 90 min at room
emperature. After five 10 min washes in TBS-T with 0.5%
ilk the membranes were incubated with enhanced chemi-
uorescence during 5 min and then analysed with a VersaDoc
000 (Biorad). The membranes were always re-probed, so
hat at least two different measures in each probed mem-
rane were obtained (internal normalization of data). Briefly,
he membranes were first incubated for 30 min with 40%
ethanol, then for 1 h at room temperature with a 0.1 M
lycine (pH 2.2) solution and then blocked as previouslyn aging of the density of presynaptic modulation systems in the
08.01.003
escribed before incubation with one of the primary anti-
odies listed above. The membranes were then washed and
ncubated with alkaline phosphatase-conjugated secondary
ntibody as described.
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.3. Statistics
Values are mean ± S.E.M. of n experiments. The signif-
cance of the effects of age was estimated with one-way
NOVA followed by Duncan’s post hoc test. A value
f P < 0.05 was considered to represent a significant
ifference.
. Results and discussion
When we investigated the age-related changes of the
ensity of proteins integrating the vesicular excoytotic
achinery, we found that the density of these proteins, often
sed as synaptic markers, was different in the different age
roups. In fact, as shown in Fig. 1A, the densities of synap-
ophysin (a protein present in synaptic vesicles; see Pinheiro
t al., 2003, and references therein) as well as the den-
ity of SNAP-25 (a membrane protein located in the active
one of nerve terminals; see Pinheiro et al., 2003, and ref-
rences therein) were larger (P < 0.05, n = 5–8) at 6 and
2 months compared to 2 months (12–15% for synapto-
hysin and 21–24% for SNAP-25). In contrast, the density
f both proteins decreased (P < 0.05, n = 4–8) at 18 months
12.4 ± 4.2% for synaptophysin and 13.3 ± 4.6% for SNAP-
5, n = 5) and 24 months (28.3 ± 3.5% for synaptophysin
nd 48.5 ± 5.1% for SNAP-25, n = 6). When the densities
f two cytoplasmatic proteins (-tubulin or GAPDH) were
sed as normalizing factors instead of total protein, synap-
ic proteins still showed a significant decrease upon aging
18–24 months). However, by this measurement, levels of
ynaptic proteins were not significantly increased after 6–12
onths because -tubulin and GAPDH densities were also
igher at 6–12 months compared to 2 months (Fig. 1B). This
ncrease of the density of -tubulin and GAPDH might be
ather non-specific and reflect changes in levels of proteins
elated with ‘house-keeping’ functions at 6–12 months of
ge. Therefore, it is concluded that there is a modification of
he density of the tested proteins associated with the vesic-
lar release apparatus which might slightly increase during
dulthood and then significantly decreases upon aging. This
ge-related decrease of presynaptic markers is in general
greement with the majority of studies reporting a decrease in
ynaptophysin mRNA and protein density and in the number
f elements immuno-positive for synaptophysin with aging
n the hippocampus and various cortical structures (Chen et
l., 1995; Eastwood et al., 1994; Frick and Fernandez, 2003;
ing and Arendash, 2002; Masliah et al., 1993; Rutten et
l., 2005; Saito et al., 1994), albeit some studies reported
ack of modification (Calhoun et al., 1998; Eastwood et al.,
006; Nicolle et al., 1999a) and even increases (Benice et al.,
006; Himeda et al., 2005) in the density of this presynapticPlease cite this article in press as: Canas, P.M., et al., Modification upo
hippocampus, Neurobiol Aging (2008), doi:10.1016/j.neurobiolaging.20
arker.
We next investigated if there was an age-related different
odification of the different types of nerve terminals. For
hat purpose, we investigated the density of markers of dif-
h
s
c
d PRESS
Aging xxx (2008) xxx–xxx 3
erent types of nerve terminals, namely vesicular glutamate
ransporters (vGluT1 and 2), vesicular GABA transporters
vGAT) and vesicular cholinergic transporters (vAChT). As
llustrated in Fig. 1C, there was an age-related continuous
ecrease of vGluT1 (significant after 18 months) and of
GluT2 (significant after 12 months). This same pattern was
bserved for vAChT (Fig. 1E), which density tended to con-
inuously decrease with age (significant after 18 months),
upporting a loss of cholinergic innervation upon aging in
he hippocampus (see Sarter and Bruno, 2004). In con-
rast, we found that the age-related change in the density
f vGAT displayed a biphasic profile, with an increase at 6
onths and a decrease at 24 months (Fig. 1D). However,
f vGAT density was normalized by comparison with the
ensity of cytoplasmatic markers (-tubulin and GAPDH),
he initial increase of vGAT density at 6 months was off-
et (since the density of -tubulin and GAPDH increased at
–12 months, see Fig. 1B) but the decrease at 24 months
as still significant (P < 0.05). To the best of our knowledge,
his constitutes the first description of age-related changes
n the density of these vesicular transporters that are widely
sed to discriminate between different types of nerve termi-
als. The results obtained indicate that there is a different
ge-related modification of the density of these markers of
ifferent nerve terminals, suggesting that there is an ini-
ial decrease of excitatory nerve terminals (glutamatergic
nd cholinergic) later followed by GABAergic nerve ter-
inals but with lower amplitude. This suggests a potential
mbalance between excitation and inhibition in hippocam-
al circuits in favor of inhibition, which would agree with
he proposed imbalance towards inhibition as a substrate of
ging-associated cognitive impairment (Wong et al., 2006).
owever, it should be noted that electrophysiological eval-
ation of excitatory versus inhibitory inputs into cortical
yramidal neurons did not reveal an imbalance with aging
Wong et al., 2000), although previous morphological stud-
es showed that the age-related decline of inhibitory buttons
s region-selective within the hippocampus (Shi et al., 2004).
n this respect, it is important to keep in mind that the present
tudy only investigated global changes of the density of dif-
erent presynaptic markers in the whole hippocampus. Since
t is known that there are different age-related changes in
ifferent hippocampal circuits (Barnes, 1994), further stud-
es should be designed to investigate if there are different
ge-related changes of these presynaptic markers in differ-
nt hippocampal areas. Therefore, although tempting, further
tudies are warranted to test if an imbalance between the
trength of excitatory and inhibitory innervations may under-
ie age-related neurophysiological changes in the different
ippocampal circuits.
The known increased excitability of principal excitatory
eurons, which is one of the hallmarks of aging in then aging of the density of presynaptic modulation systems in the
08.01.003
ippocampus, might also result from the different intrin-
ic efficiency of presynaptic modulation systems. We now
onfirmed that there was an age-related reduction in the
ensity of inhibitory A1 receptors (Fig. 2A), in agreement
Please cite this article in press as: Canas, P.M., et al., Modification upon aging of the density of presynaptic modulation systems in the
hippocampus, Neurobiol Aging (2008), doi:10.1016/j.neurobiolaging.2008.01.003
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Fig. 1. Age-related changes in the density of presynaptic markers (synaptophysin and SNAP-25 (A)), general cytoplasmatic markers (-tubulin and
glyceraldeheyde-3-phosphate dehydrogenase, GAPDH (B)), markers of glutamatergic terminals (vesicular glutamate transporters types 1 and 2, vGluT1
and 2 (C)), markers of GABAergic terminals (vesicular GABA transporter, vGAT (D)) and markers of cholinergic terminals (vesicular acetylcholine trans-
porter, vAChT (E)) in nerve terminals purified from the hippocampus of rats with different ages (2, 6, 12, 18 and 24 months). Each panel displays the percentage
density of each protein compared to its density at 2 months and the data was derived from Western blot analysis similar to that indicated below each graph
where all age groups were simultaneously evaluated. The results are mean ± S.E.M. of 4–8 animals in each age group. *P < 0.05 compared to 2 months.
ARTICLE IN PRESSNBA-7009; No. of Pages 8
P.M. Canas et al. / Neurobiology of Aging xxx (2008) xxx–xxx 5
Fig. 2. Age-related changes in the density of receptors operating presynaptic modulation systems that have been targeted as neuroprotective strategies, namely
adenosine A1 receptors (A), cannabinoid CB1 receptors (B), adenosine A2A receptors (C), glutamate metabotropic group 5 receptors (mGluR5 (D)) and
p mpus of
t and the
e ts are m
m
w
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A
a
t
p
e
a
o
eurinergic P2Y1 receptors (E) in nerve terminals purified from the hippoca
he percentage density of each receptor compared to its density at 2 months
ach graph where all age groups were simultaneously evaluated. The resul
onths.
ith previous observations (Cheng et al., 2000; Cunha et al.,
995; Pagonopoulou and Angelatou, 1992). This powerful
1 receptor-mediated presynaptic inhibitory system mostlyPlease cite this article in press as: Canas, P.M., et al., Modification upo
hippocampus, Neurobiol Aging (2008), doi:10.1016/j.neurobiolaging.20
ffects excitatory rather than inhibitory transmission in cor-
ical circuits (reviewed in Fredholm et al., 2005) and we have
reviously shown that the A1 receptor-mediated inhibition of
xcitatory transmission in the hippocampus is decreased in
O
r
i
arats with different ages (2, 6, 12, 18 and 24 months). Each panel displays
data was derived from Western blot analysis similar to that indicated below
ean ± S.E.M. of 4–8 animals in each age group. *P < 0.05 compared to 2
ged rats (Sebastia˜o et al., 2000). Thus, the reduced density
f A1 receptors in aged rats may contribute for the increased
xcitability of principal neurons upon aging (Barnes, 1994).n aging of the density of presynaptic modulation systems in the
08.01.003
n the hand, it also suggests that strategies targeting A1
eceptors to manage neurodegenerative diseases (reviewed
n Fredholm et al., 2005) may be less efficient in aged
nimals.
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The density of cannabinoid CB1 receptors, which oper-
tes another presynaptic inhibitory modulation system (van
er Stelt and Di Marzo, 2005) was also found to be decreased
ith aging (Fig. 2B). This is in agreement with the age-related
ecreased expression of CB1 receptors in the hippocam-
us (Berrendero et al., 1998), although different age-related
hanges in CB1 protein density were reported in different cor-
ical regions (Berrendero et al., 1998; Liu et al., 2003; Mato
nd Pazos, 2004). In contrast to A1 receptors, CB1 recep-
ors inhibit both excitatory and inhibitory transmission in the
ippocampus (van der Stelt and Di Marzo, 2005), although
he neuroprotective effects associated with CB1 receptors
ere ascribed to glutamatergic rather than GABAergic effects
Monory et al., 2006). However, this decrease in the density
f CB1 receptors with aging suggests that the efficacy of tar-
eting CB1 receptors to manage neuronal dysfunction in the
lderly might be lower than that anticipated based on the
tudies carried out in young adults.
In contrast to the age-related change in the density of the
eceptors operating these two main presynaptic inhibitory
ystems, we found a significant increase in the density of the
denosine A2A receptors (Fig. 1C). A2A receptors trigger a
resynaptic facilitation system which increases glutamater-
ic transmission and plasticity (reviewed in Fredholm et al.,
005) and the present results confirm previous observations
hat the increased density of hippocampal A2A receptors
ainly occurs from middle-aged to aged animals (Rebola
t al., 2003a). This age-related increase of the density of
2A receptors is particularly interesting in view of the ability
f A2A receptor antagonists to restore memory dysfunction
ssociated with aging (Prediger et al., 2005) and neurodegen-
rative diseases (Dall’Igna et al., 2007).
Another facilitation system which antagonism affords
europrotection is operated by metabotropic group 5 recep-
ors (mGluR5), although their mechanism of action is still
nclear due to their pre-, post- and non-neuronal local-
zation (reviewed in Flor et al., 2002). It has previously
een reported that the global ability of mGluR5 to recruit
hosphoinositide turnover is blunted (Nicolle et al., 1999b),
hereas their post-synaptic effects on membrane properties
re largely preserved in aged rats (Jouvenceau et al., 1997)
n agreement with the preservation of mGluR5 density in
he aged hippocampus (Jouvenceau et al., 1997; Nicolle et
l., 1999b; Simonyi et al., 2005). We now observed that the
ensity of mGluR5 increased at 6 months and was main-
ained throughout aging, with only a marginal reduction
bserved at 24 months (Fig. 2D). In fact, the normalization
f mGluR5 density using cytoplasmatic markers (-tubulin
nd GAPDH) offsets any significant modifications of the
ensity of mGluR5 (P > 0.05). This suggests that the synapto-
rotective effects associated with the control of mGluR5
ction might essentially be preserved with aging.Please cite this article in press as: Canas, P.M., et al., Modification upo
hippocampus, Neurobiol Aging (2008), doi:10.1016/j.neurobiolaging.20
Finally, the last presynaptic modulation system investi-
ated in this study was the P2Y1 receptor. We have recently
ound that the blockade of this receptor affords a robust
europrotection against damage of hippocampal neurons in
p
T
T
A PRESS
Aging xxx (2008) xxx–xxx
ifferent models of excitotoxicity (unpublished results) in
greement with the neuroprotection afforded by P2Y recep-
or antagonists in in vivo models of ischemia (Franke et al.,
006). We now found that the density of presynaptic hip-
ocampal P2Y1 receptors is similar (P > 0.05) in all age
roups tested (Fig. 2E). This indicates that this presynaptic
odulation is preserved upon aging, suggesting that it may be
n interesting target to control age-related neurodegenerative
rocesses.
When evaluated globally, the results obtained prompt a
rend in terms of age-related changes in the density of presy-
aptic modulation systems. In fact, there seems to be a clear
eduction in the density of receptors operating inhibitory sys-
ems (A1 and CB1 receptors) paralleled by a trend towards
he preservation (mgluR5) or clear increase (A2A recep-
ors) of presynaptic facilitation systems. This is a remarkable
greement with the hallmark of increased excitability that
haracterizes principal neurons in hippocampal circuits of
ged rats. However, the age-related changes described in this
tudy are total changes in the density of receptors and trans-
orters, which do not discriminate between intracellular and
embrane bound proteins. Hence, the present findings do
ot provide information about eventual changes in receptor
eserve. Therefore, this tentative relation based on the age-
elated changes in the density of protein receptors still needs
o be explored at the functional level. Another interesting
nference derived from the data presented is that the neuro-
rotective strategies targeting presynaptic modulation system
hat seem best fitted to be transposed to the management of
eurodegenerative diseases in the elderly are these based on
he use of antagonists. In fact, antagonists of mGluR5, A2A
nd P2Y1 receptors are proposed as candidate neuroprotec-
ive strategies and the density of these presynaptic receptors
s either preserved or increased on aging. In contrast, agonists
f A1 and CB1 receptors are proposed as candidate neu-
oprotective strategies and the density of these presynaptic
eceptors is decreased. This prompts the question of whether
he age-related decrease of these inhibitory receptor systems
s due to their intense recruitment to counteract age-related
eleterious changes in hippocampal circuits. Conversely,
he participation of each of the facilitation receptors in the
ge-related changes of neuronal circuits is still an open
uestion.
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